Target intelligence / Profile preview

SON DNA binding protein (SON) (SON)

Target
SON
Molecular classification
DNA-binding protein, RNA-binding protein, Splicing cofactor, Transcription factor, Nuclear speckle scaffold protein
01

Overview

SON DNA binding protein (SON) is a large, multifunctional nuclear protein that serves as a critical scaffold for nuclear speckles and a co-factor for pre-mRNA splicing. It is particularly essential for the efficient splicing of transcripts with weak or suboptimal splice sites, many of which encode proteins involved in cell cycle progression, DNA repair, and centrosome assembly. Beyond its role in RNA processing, SON acts as a transcriptional repressor, notably for the hepatitis B virus core promoter, and regulates hematopoietic stem cell fate. In clinical contexts, heterozygous loss-of-function mutations in the SON gene cause Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome, a rare multisystem developmental disorder characterized by intellectual disability and brain malformations. Conversely, SON is often overexpressed in various cancers, including pancreatic cancer and leukemia, where it promotes cell survival and tumorigenicity, making it a potential therapeutic target. Recent research has also identified small molecules like pyrvinium pamoate that interact with SON to modulate nuclear speckle dynamics, offering a potential strategy for treating proteinopathies such as Alzheimer's disease.

Other names
Protein SONBax antagonist selected in Saccharomyces 1BASS1Negative regulatory element-binding proteinNREBPProtein DBP-5SON3C21orf50KIAA1019
02

Mechanism of action

Modulation of nuclear speckle dynamics and protein quality control via interaction with the intrinsically disordered region of SON; inhibition of oncogenic splicing and cell cycle progression.

03

Biological functions

mRNA splicingCell cycle regulationTranscription repressionNuclear speckle organizationHematopoietic stem cell maintenanceAutophagy
04

Disease associations

Zhu-Tokita-Takenouchi-Kim syndromeCancerViral infectionAlzheimer's diseaseTauopathy
05

Safety considerations

Haploinsufficiency causes ZTTK syndromeEssential for normal cell cycle progressionPotential for systemic toxicity due to broad role in splicing
06

Interacting drugs

Pyrvinium pamoate
07

Biomarkers

SON gene mutationsSON protein expression levelsAberrant splicing of PRRT2Aberrant splicing of TUBG1

Beyond the preview

Go deeper on SON DNA binding protein (SON) (SON).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SON DNA binding protein (SON) (SON).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call